Prapela wins NIH funding for newborn apnea treatment device

Infant health company Prapela has received a grant from the National Institutes of Health’s (NIH) Blueprint MedTech programme and National Institute on Drug Abuse (NIDA) to support the development of a medical device to better treat apnea in preterm newborns.

Read full article.